Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Chemed Corp (NY:CHE)

421.40 +11.39 (+2.78%)
Official Closing Price Updated: 4:10 PM EST, Mar 2, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Chemed Corp

< Previous 1 2 3 4 5 Next >
News headline image
Why Chemed (CHE) Shares Are Plunging Today
Shares of healthcare services company Chemed Corporation (NYSE:CHE) fell 15.6% in the afternoon session after the company reported financial results for the fourth quarter of 2025 that missed Wall... 
Via StockStory
News headline image
Chemed (CHE) Q4 2025 Earnings Call Transcript ↗
Chemed (CHE) Q4 2025 Earnings Call Transcript 
Via The Motley Fool
Topics Earnings
Chemed Corp. (NYSE:CHE) Shares Drop on Q4 Earnings and Revenue Miss ↗
Via Chartmill
News headline image
Chemed (NYSE:CHE) Reports Sales Below Analyst Estimates In Q4 CY2025 Earnings, Stock Drops 14.7%
Healthcare services company Chemed Corporation (NYSE:CHE) fell short of the market’s revenue expectations in Q4 CY2025, with sales flat year on year at $639.3 million. Its non-GAAP profit of $6.42 per... 
Via StockStory
News headline image
Earnings Scheduled For October 28, 2025 ↗
 
Via Benzinga
News headline image
Earnings Outlook For Chemed ↗
 
Via Benzinga
News headline image
Chemed (CHE) To Report Earnings Tomorrow: Here Is What To Expect
Healthcare services company Chemed Corporation (NYSE:CHE) will be reporting earnings this Wednesday afternoon. Here’s what to look for. 
Via StockStory
Topics Artificial Intelligence World Trade
News headline image
1 Cash-Producing Stock to Consider Right Now and 2 We Find Risky
A company that generates cash isn’t automatically a winner. Some businesses stockpile cash but fail to reinvest wisely, limiting their ability to expand. 
Via StockStory
Topics Economy
News headline image
3 Reasons to Sell CHE and 1 Stock to Buy Instead
Chemed trades at $473.22 per share and has stayed right on track with the overall market, gaining 6.4% over the last six months. At the same time, the S&P 500 has returned 6%. 
Via StockStory
Topics Stocks
News headline image
Chemed Stock Down 15% in a Year as One Fund Builds a $5.56 Million Stake ↗
Chemed Corporation delivers hospice care and essential home services nationwide through its VITAS and Roto-Rooter segments. 
Via The Motley Fool
Topics Regulatory Compliance
News headline image
1 Profitable Stock on Our Watchlist and 2 That Underwhelm
While profitability is essential, it doesn’t guarantee long-term success. Some companies that rest on their margins will lose ground as competition intensifies - as Jeff Bezos said, "Your margin is my... 
Via StockStory
News headline image
3 Healthcare Stocks We Steer Clear Of
Personal health and wellness is one of the many secular tailwinds for healthcare companies. Shareholders who bet on the industry have been rewarded lately as healthcare stocks have returned 18.6% over... 
Via StockStory
Topics Stocks
News headline image
1 Small-Cap Stock to Target This Week and 2 We Avoid
Many small-cap stocks have limited Wall Street coverage, giving savvy investors the chance to act before everyone else catches on. But the flip side is that these businesses have increased downside... 
Via StockStory
News headline image
3 Low-Volatility Stocks We Find Risky
Low-volatility stocks may offer stability, but that often comes at the cost of slower growth and the upside potential of more dynamic companies. 
Via StockStory
News headline image
Why Chemed (CHE) Shares Are Sliding Today
Shares of healthcare services company Chemed Corporation (NYSE:CHE) fell 4.2% in the afternoon session after Jefferies downgraded the stock to 'Hold' from 'Buy' and slashed its price target. 
Via StockStory
News headline image
1 of Wall Street’s Favorite Stock to Consider Right Now and 2 Facing Challenges
Wall Street is overwhelmingly bullish on the stocks in this article, with price targets suggesting significant upside potential. However, it’s worth remembering that analysts rarely issue sell ratings,... 
Via StockStory
News headline image
3 Out-of-Favor Stocks We Think Twice About
Rock-bottom prices don't always mean rock-bottom businesses. The stocks we're examining today have all touched their 52-week lows, creating a classic investor's dilemma: bargain opportunity or value... 
Via StockStory
Topics Bonds
News headline image
3 Small-Cap Stocks We Approach with Caution
Investors looking for hidden gems should keep an eye on small-cap stocks because they’re frequently overlooked by Wall Street. Many opportunities exist in this part of the market, but it is also a... 
Via StockStory
News headline image
Senior Health, Home Health & Hospice Stocks Q3 Highlights: Chemed (NYSE:CHE)
As the Q3 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the senior health, home health & hospice industry, including Chemed (NYSE:CHE) and its... 
Via StockStory
Topics Economy
News headline image
Natera, Amneal, Chemed, The Pennant Group, and HCA Healthcare Shares Are Soaring, What You Need To Know
A number of stocks jumped in the afternoon session after comments from a key Federal Reserve official bolstered hopes for an interest rate cut. New York Federal Reserve President John Williams stated... 
Via StockStory
Topics Economy
News headline image
Senior Health, Home Health & Hospice Stocks Q3 Highlights: Chemed (NYSE:CHE)
The end of the earnings season is always a good time to take a step back and see who shined (and who not so much). Let’s take a look at how senior health, home health & hospice stocks fared in Q3,... 
Via StockStory
Topics Economy
News headline image
5 Revealing Analyst Questions From Chemed’s Q3 Earnings Call
Chemed’s third quarter was marked by continued operational challenges in both the VITAS and Roto-Rooter businesses, resulting in a negative market reaction. Management attributed the margin compression... 
Via StockStory
Topics Earnings
News headline image
Schwartz Offloads 28,000 Chemed (CHE) Shares Valued at $13 Million ↗
Schwartz Offloads 28,000 Chemed (CHE) Shares Valued at $13 Million 
Via The Motley Fool
Topics Regulatory Compliance
News headline image
EULAV Asset Management Unloads $13 Million of Chemed (NYSE: CHE) Stock: Should Investors Sell Too? ↗
EULAV Asset Management Unloads $13 Million of Chemed (NYSE: CHE) Stock: Should Investors Sell Too? 
Via The Motley Fool
News headline image
CHE Q3 CY2025 Deep Dive: Margin Pressure Persists Despite Operational Progress in Core Segments
Healthcare services company Chemed Corporation (NYSE:CHE) met Wall Streets revenue expectations in Q3 CY2025, with sales up 3.1% year on year to $624.9 million. Its non-GAAP profit of $5.27 per share... 
Via StockStory
News headline image
Why Are Chemed (CHE) Shares Soaring Today
Shares of healthcare services company Chemed Corporation (NYSE:CHE) jumped 8.5% in the afternoon session after investors looked past a third-quarter earnings miss and focused instead on the company's... 
Via StockStory
Topics Earnings
News headline image
Caterpillar Posts Upbeat Q3 Results, Joins United Therapeutics, Centene, Fortive And Other Big Stocks Moving Higher On Wednesday ↗
 
Via Benzinga
News headline image
Chemed’s (NYSE:CHE) Q3 Earnings Results: Revenue In Line With Expectations
Healthcare services company Chemed Corporation (NYSE:CHE) met Wall Street’s revenue expectations in Q3 CY2025, with sales up 3.1% year on year to $624.9 million. Its non-GAAP profit of $5.27 per share... 
Via StockStory
News headline image
Chemed (CHE) Q3 Earnings: What To Expect
Healthcare services company Chemed Corporation (NYSE:CHE) will be announcing earnings results this Tuesday after market hours. Here’s what you need to know. 
Via StockStory
Topics Artificial Intelligence
News headline image
1 Cash-Producing Stock with Competitive Advantages and 2 We Brush Off
Generating cash is essential for any business, but not all cash-rich companies are great investments. Some produce plenty of cash but fail to allocate it effectively, leading to missed opportunities. 
Via StockStory
< Previous 1 2 3 4 5 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.